MoonLake (NASDAQ:MLTX) Azioni, Quote.MetaTitle.unusual-options

MoonLake

MoonLake Immunotherapeutics - Class A Ordinary Shares

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

Comments

MoonLake Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO